| 000 | 03014nam a22003855i 4500 | ||
|---|---|---|---|
| 001 | 100403 | ||
| 003 | DE-He213 | ||
| 005 | 20230102112954.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180704s2018 si | s |||| 0|eng d | ||
| 020 |
_a9789811069437 _9 |
||
| 024 | 7 |
_a10.1007/978-981-10-6943-7 _2doi |
|
| 040 |
_aES-MaUEC _bspa |
||
| 050 | 4 | _aRC280.P7 2018 EB | |
| 245 | 0 | 0 |
_aManagement of Advanced Prostate Cancer _cedited by Choung Soo Kim. |
| 264 | 1 |
_aSingapore _bSpringer International Publishing _c2018 |
|
| 300 | _a1 recurso en línea (IX, 201 páginas 11 ilustraciones, 8 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 505 | 0 | _aSection 1. Surgery for advanced prostate cancer -- Section 2 Radiotherapy for advanced prostate cancer -- Section 3. Androgen deprivation therapy for advanced prostate cancer -- Section 4. Chemotherapy and immunotherapy and palliative care for advanced prostate cancer. | |
| 520 | 3 | _aThis textbook summarizes the state of the art in the management of locally advanced and metastatic prostate cancer with the aim of providing the knowledge required for optimal treatment decision making in individual cases. Readers will find comprehensive coverage of the latest developments in surgery, radiotherapy, androgen deprivation therapy (ADT), chemotherapy, and immunotherapy. The role of the hormonal therapies abiraterone and enzalutamide and docetaxel-based chemotherapy in castration-resistant prostate cancer and hormone-sensitive metastatic disease is carefully evaluated. Among the other therapies discussed are LHRH agonists and antagonists, cabazitaxel, radium-223, and various novel agents still under clinical trials. The section on surgical approaches addresses, among other topics, the use of robot-assisted radical prostatectomy, pelvic lymphadenectomy, and the benefits of adjuvant and neoadjuvant therapy. The current role of external beam radiotherapy, alone or in combination with ADT and brachytherapy, for locally advanced disease is reviewed. Management of Advanced Prostate Cancer will be a valuable resource for practitioners at all levels of expertise. | |
| 650 | 7 |
_aOncología _2embne _9139207 |
|
| 650 | 7 |
_aPróstata _xCáncer _2embne _9182337 |
|
| 700 | 1 |
_aKim, Choung Soo. _eeditor literario |
|
| 710 | 2 |
_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _0http://viaf.org/viaf/148105729 _9106996 |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9789811069420 |
| 776 | 0 | 8 |
_iEdición impresa: _z9789811069444 |
| 776 | 0 | 8 |
_iEdición impresa: _z9789811329333 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-6943-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 490 | 0 | _aMedicine (Springer-11650) | |
| 988 | _aSpringer_Medicine_2018 | ||
| 998 |
_b01/2019 _dz _ea _feng _ggw _h0 |
||
| 999 |
_c100403 _d100403 _x1 |
||